Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Somya Ranjan Dash
Observed name:
Dash, Somya Ranjan
Institutions:
Indian Institute of Science Education and Research Berhampur,
KIIT University
Observed institutions:
Indian Institute of Science Education and Research, Bhopal,
Indian Institute of Science Education and Research Berhampur,
Department of Biological Sciences,
Department of Biological Sciences,
KIIT University
ORCID:
0000-0001-7407-9338
Observed ORCID:
0000-0001-7407-9338
OpenAlex ID:
A5060177679
Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway
2022
·
Rajalaxmi Pradhan
, Subarno Paul
, et al.
·
The Journal of Nutritional Biochemistry
·
49
Nectin-4 promotes lymphangiogenesis and lymphatic metastasis in breast cancer by regulating CXCR4-LYVE-1 axis
2021
·
Chinmayee Sethy
, Kunal Goutam
, et al.
·
Vascular Pharmacology
·
45
Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis
2024
·
Rajalaxmi Pradhan
, Subarno Paul
, et al.
·
The Journal of Nutritional Biochemistry
·
41
Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells
2023
·
Biswajit Das
, Somya Ranjan Dash
, et al.
·
Phytomedicine
·
29
Promising opportunities and potential risk of nanoparticle on the society
2020
·
Somya Ranjan Dash
, Chanakya Nath Kundu
·
IET Nanobiotechnology
·
29
PDF
Advances in nanomedicine for the treatment of infectious diseases caused by viruses
2023
·
Somya Ranjan Dash
, Chanakya Nath Kundu
·
Biomaterials Science
·
28
Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells
2023
·
Subarno Paul
, Subhajit Chatterjee
, et al.
·
Expert Opinion on Therapeutic Targets
·
26
Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway
2022
·
Saptarshi Sinha
, Subhajit Chatterjee
, et al.
·
Experimental Cell Research
·
26
Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping
2022
·
Subhajit Chatterjee
, Ajit Kumar Dhal
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
24
NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells
2021
·
Somya Ranjan Dash
, Subhajit Chatterjee
, et al.
·
Nanomedicine Nanotechnology Biology and Medicine
·
23
Photothermal Therapy: A New Approach to Eradicate Cancer
2021
·
Somya Ranjan Dash
, Chanakya Nath Kundu
·
Current Nanoscience
·
23
Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells
2020
·
Krushna Chandra Hembram
, Somya Ranjan Dash
, et al.
·
Molecular Pharmaceutics
·
22
Near-Infrared Enhances Antiangiogenic Potentiality of Quinacrine-Gold Hybrid Nanoparticles in Breast Cancer Stem Cells Via Deregulation of HSP-70/TGF-β
2023
·
Somya Ranjan Dash
, Biswajit Das
, et al.
·
Nanomedicine
·
17
Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300
2023
·
Chinmay Das
, Somya Ranjan Dash
, et al.
·
Medical Oncology
·
16
PDF
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation
2024
·
Saptarshi Sinha
, Subarno Paul
, et al.
·
Medical Oncology
·
15
Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells
2023
·
Biswajit Das
, Chinmayee Sethy
, et al.
·
Journal of Cell Communication and Signaling
·
12
PDF
The role of viruses in cancer progression versus cancer treatment: A dual paradigm
2024
·
Somya Ranjan Dash
, Anushka Kundu
, et al.
·
Life Sciences
·
10
Near Infrared-Responsive Quinacrine–Gold Hybrid Nanoparticles Deregulate HSP-70/P300-Mediated H3K14 Acetylation in ER/PR+ Breast Cancer Stem Cells
2024
·
Somya Ranjan Dash
, Chinmay Das
, et al.
·
Nanomedicine
·
6
Cancer-induced Pain Management by Nanotechnology-based Approach
2023
·
Chanakya Nath Kundu
, Somya Ranjan Dash
·
Current Pharmaceutical Biotechnology
·
4
Surface functionalized gold nanorods for plasmonic photothermal therapy
2021
·
Rupayana Panda
, Somya Ranjan Dash
, et al.
·
Materials Today Proceedings
·
4
Determining the effect of long non-coding RNA maternally expressed gene 3 (lncRNA MEG3) on the transcriptome profile in cervical cancer cell lines
2024
·
Solomon Arega
, Suchanda Dey
, et al.
·
Genomics
·
3
Talazoparib enhances the anti-angiogenic potential of quinacrine through the deregulation of P300 and GCN5 chromatin remodelers in patient-derived oral cancer stem cells
2026
·
Chinmay Das
, Subarno Paul
, et al.
·
3 Biotech
·
1
5-FU in combination with PARP inhibitor ABT-888 deregulates MGMT-dependent mismatch repair (MMR) pathway in MMR-proficient colorectal cancer stem cells by modulating MGMT/PARP1/MSH6 complex
2026
·
Subarno Paul
, Chinmay Das
, et al.
·
Figshare
5-FU in combination with PARP inhibitor ABT-888 deregulates MGMT-dependent mismatch repair (MMR) pathway in MMR-proficient colorectal cancer stem cells by modulating MGMT/PARP1/MSH6 complex
2026
·
Subarno Paul
, Chinmay Das
, et al.
·
Expert Opinion on Therapeutic Targets
Metabolic Cross Talk in the Tumor Microenvironment
2026
·
Chinmay Das
, Somya Ranjan Dash
, et al.
·
Cancer treatment and research
Show more works
View as search
Works count:
30
Citation count:
453
H-index:
15
I10-index:
17
Year
Topic
Type